A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 29, Issue 12, Pages 4829-4839
Publisher
FASEB
Online
2015-08-01
DOI
10.1096/fj.15-274050
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades
- (2015) Yiyan Sui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma
- (2014) Y. X. Zhu et al. BLOOD
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
- (2014) Philip P Chamberlain et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Mental Retardation-linked Nonsense Mutation in Cereblon Is Rescued by Proteasome Inhibition
- (2013) Guoqiang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma
- (2013) Yandun Zou et al. LEUKEMIA & LYMPHOMA
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
- (2012) A. Broyl et al. BLOOD
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- Functional modulation of AMP-activated protein kinase by cereblon
- (2011) Kwang Min Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- The Molecular Basis of CRL4DDB2/CSA Ubiquitin Ligase Architecture, Targeting, and Activation
- (2011) Eric S. Fischer et al. CELL
- mRNA distribution of the thalidomide binding protein cereblon in adult mouse brain
- (2011) Miho Aizawa et al. NEUROSCIENCE RESEARCH
- Temporal and Spatial Mouse Brain Expression of Cereblon, An Ionic Channel Regulator Involved in Human Intelligence
- (2010) Joseph J. Higgins et al. JOURNAL OF NEUROGENETICS
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- GeneCards Version 3: the human gene integrator
- (2010) M. Safran et al. Database-The Journal of Biological Databases and Curation
- Autoubiquitination of BCA2 RING E3 Ligase Regulates Its Own Stability and Affects Cell Migration
- (2008) Y. Amemiya et al. MOLECULAR CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started